An Analysis of the Role of HnRNP C Dysregulation in Cancers

Overview

Journal Biomark Res

Publisher Biomed Central

Date 2022 Apr 9

PMID 35395937

Authors

Liyi Mo

Lijuan Meng

Zhicheng Huang

Lan Yi

Nanyang Yang

Guoqing Li

Affiliations

Soon will be listed here.

Abstract

Heterogeneous nuclear ribonucleoproteins C (HnRNP C) is part of the hnRNP family of RNA-binding proteins. The relationship between hnRNP C and cancers has been extensively studied, and dysregulation of hnRNP C has been found in many cancers. According to existing public data, hnRNP C could promote the maturation of new heterogeneous nuclear RNAs (hnRNA s, also referred to as pre-mRNAs) into mRNAs and could stabilize mRNAs, controlling their translation. This paper reviews the regulation and dysregulation of hnRNP C in cancers. It interacts with some cancer genes and other biological molecules, such as microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and double-stranded RNAs (dsRNAs). Even directly binds to them. The effects of hnRNP C on biological processes such as alternative cleavage and polyadenylation (APA) and N6-methyladenosine (m6A) modification differ among cancers. Its main function is regulating stability and level of translation of cancer genes, and the hnRNP C is regarded as a candidate biomarker and might be valuable for prognosis evaluation.

Citing Articles

circASAP1 induces renal clear cell carcinoma ferroptosis by binding to HNRNPC and thereby regulating GPX4.

Wang Y, Yang T, Li Q, Zheng Z, Liao L, Cen J Mol Cancer. 2025; 24(1):1.

PMID: 39748364 PMC: 11694429. DOI: 10.1186/s12943-024-02122-8.

Heterogeneous nuclear ribonucleoprotein D - an understudied subfamily affected in sporadic TDP-43 proteinopathies.

Pinkerton M, Adler G, Ledger M, Ni C, Yang Y, Tan R Brain Commun. 2024; 6(6):fcae352.

PMID: 39670112 PMC: 11635367. DOI: 10.1093/braincomms/fcae352.

hnRNPs: roles in neurodevelopment and implication for brain disorders.

Tilliole P, Fix S, Godin J Front Mol Neurosci. 2024; 17:1411639.

PMID: 39086926 PMC: 11288931. DOI: 10.3389/fnmol.2024.1411639.

Exploring protein relative relations in skeletal muscle proteomic analysis for insights into insulin resistance and type 2 diabetes.

Czajkowska A, Czajkowski M, Szczerbinski L, Jurczuk K, Reska D, Kwedlo W Sci Rep. 2024; 14(1):17631.

PMID: 39085321 PMC: 11292014. DOI: 10.1038/s41598-024-68568-4.

The role of alternative polyadenylation in breast cancer.

Qiao P, Zhang C, Shi Y, Du H Front Genet. 2024; 15:1377275.

PMID: 38939531 PMC: 11208690. DOI: 10.3389/fgene.2024.1377275.

References

Kleemann M, Schneider H, Unger K, Sander P, Schneider E, Fischer-Posovszky P . MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells. Sci Rep. 2018; 8(1):9020. PMC: 5998049. DOI: 10.1038/s41598-018-27438-6. View

Swanson M, Nakagawa T, Levan K, Dreyfuss G . Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol Cell Biol. 1987; 7(5):1731-9. PMC: 365274. DOI: 10.1128/mcb.7.5.1731-1739.1987. View

McCloskey A, Taniguchi I, Shinmyozu K, Ohno M . hnRNP C tetramer measures RNA length to classify RNA polymerase II transcripts for export. Science. 2012; 335(6076):1643-6. DOI: 10.1126/science.1218469. View

Vance K, Sansom S, Lee S, Chalei V, Kong L, Cooper S . The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J. 2014; 33(4):296-311. PMC: 3983687. DOI: 10.1002/embj.201386225. View

Huang G, Wu Q, Zheng Z, Shao T, Chen Y, Zeng W . M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT. Aging (Albany NY). 2020; 12(12):11667-11684. PMC: 7343469. DOI: 10.18632/aging.103333. View

Su Z, Liu X, Xu Y, Hu W, Zhao C, Zhao H . Novel reciprocal fusion genes involving and in acute promyelocytic leukemia lacking rearrangement. Haematologica. 2020; 105(7):e376-e378. PMC: 7327640. DOI: 10.3324/haematol.2019.244715. View

Wang L, Chen S, Shen X, Li D, Liu H, Ji Y . M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Front Oncol. 2020; 10:536875. PMC: 7578363. DOI: 10.3389/fonc.2020.536875. View

Masamha C, Xia Z, Yang J, Albrecht T, Li M, Shyu A . CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature. 2014; 510(7505):412-6. PMC: 4128630. DOI: 10.1038/nature13261. View

Ferre F, Colantoni A, Helmer-Citterich M . Revealing protein-lncRNA interaction. Brief Bioinform. 2015; 17(1):106-16. PMC: 4719072. DOI: 10.1093/bib/bbv031. View

10.

Visa N, Sun X, Kiseleva E, Bjorkroth B, Wurtz T, Daneholt B . A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes. Cell. 1996; 84(2):253-64. DOI: 10.1016/s0092-8674(00)80980-0. View

11.

Fischl H, Neve J, Wang Z, Patel R, Louey A, Tian B . hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles. Nucleic Acids Res. 2019; 47(14):7580-7591. PMC: 6698646. DOI: 10.1093/nar/gkz461. View

12.

Xia Z, Donehower L, Cooper T, Neilson J, Wheeler D, Wagner E . Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nat Commun. 2014; 5:5274. PMC: 4467577. DOI: 10.1038/ncomms6274. View

13.

Torroja L, Packard M, GORCZYCA M, White K, Budnik V . The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J Neurosci. 1999; 19(18):7793-803. PMC: 6782486. View

14.

Choi Y, Grabowski P, Sharp P, Dreyfuss G . Heterogeneous nuclear ribonucleoproteins: role in RNA splicing. Science. 1986; 231(4745):1534-9. DOI: 10.1126/science.3952495. View

15.

Huang M, Rech J, Northington S, Flicker P, Mayeda A, Krainer A . The C-protein tetramer binds 230 to 240 nucleotides of pre-mRNA and nucleates the assembly of 40S heterogeneous nuclear ribonucleoprotein particles. Mol Cell Biol. 1994; 14(1):518-33. PMC: 358402. DOI: 10.1128/mcb.14.1.518-533.1994. View

16.

Shen Y, Liu S, Fan J, Jin Y, Tian B, Zheng X . Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep. 2017; 18(4):536-548. PMC: 5376760. DOI: 10.15252/embr.201643139. View

17.

Hwang S, Seol H, Park Y, Kim K, Gorospe M, Nam D . MicroRNA-146a suppresses metastatic activity in brain metastasis. Mol Cells. 2012; 34(3):329-34. PMC: 3887840. DOI: 10.1007/s10059-012-0171-6. View

18.

Kim J, Paek K, Choi K, Kim T, Hahm B, Kim K . Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner. Mol Cell Biol. 2003; 23(2):708-20. PMC: 151538. DOI: 10.1128/MCB.23.2.708-720.2003. View

19.

Parker B, Rautela J, Hertzog P . Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016; 16(3):131-44. DOI: 10.1038/nrc.2016.14. View

20.

Zhou K, Parisien M, Dai Q, Liu N, Diatchenko L, Sachleben J . N(6)-Methyladenosine Modification in a Long Noncoding RNA Hairpin Predisposes Its Conformation to Protein Binding. J Mol Biol. 2015; 428(5 Pt A):822-833. PMC: 4779075. DOI: 10.1016/j.jmb.2015.08.021. View